
Free CDCES Coach App

eNewsletter
Free Med Pocket Cards
Featured Articles ___________________________ |
Greetings, wonderful healthcare colleagues!
You are going to love all the updates to our cheat sheets, online university courses, and PocketCards.
Coach Beverly has been excitedly scanning the 2026 ADA Standards to discover updates and advances in diabetes care. She and her team are hustling to integrate these new findings across our platforms, including the CDCES Coach App, handouts, courses, and web content, so that you can access the latest information with confidence.
In our first newsletter of 2026, we are excited to share that we have made significant changes to our Medication PocketCards in the GLP-1/GIP RA section. Now included are the diabetes and weight-loss versions of this popular medication class, with indications for each. You can compare and contrast at a glance. Download your free version and read more below.
Our library of Cheat Sheets is updated and includes a few new additions! These sheets are available on our website and the CDCES Coach App for easy access, with the option to download and share with your colleagues and people living with diabetes alike.
Christine Craig, MS, RD, CDCES, explores her experience with a client who arrived at her office distraught and struggling with the loss of his lifelong partner. Pass the tissues.
Our Tech contributor, Dr. Beattie, provides a summary of red flag statements that may indicate a person is experiencing barriers to effectively using technology in their day-to-day management.
We encourage you to test your knowledge with our Question and Rationale of the Week. January kicks off our Level 1 Fundamental Series, followed by our annual ADA Standards of Care update on January 29th and Level 2 Mastery Course Series in February. We hope to see you there!
Here is to a 2026 filled with self-compassion and moments of awe.
Coach Beverly, Bryanna, Astraea & Katarina
For last week’s practice question, we quizzed participants on Katie needing support with improving her glycemic management, and what would be the best response. 76.5% of respondents chose the best answer. We want to clarify and share this important information, so you can pass it on to people living with diabetes and your colleagues, plus prepare for exam success!
Before we start though, if you don’t want any spoilers and haven’t tried the question yet, you can answer it below: Answer Question

Katie is a 14-year-old living with type 1 diabetes since age 10. She uses multiple daily insulin injections (MDI) therapy to manage her diabetes and started using a continuous glucose monitor (CGM) 3 months ago at the recommendation of her endocrinology team. Her A1c has increased to 9.2% since starting CCM technology.
Her mother reports that Katie has episodes of prolonged hyperglycemia when she is away from home. When at home, her mother will remind Katie to bolus based on the alerts she gets on the CGM share app. Katie reports she mutes alarms and alerts because she doesn’t want her classmates to hear them, afraid they will judge her. When you ask if she has uploaded her data to the school nurse or her endocrinology team she says, “The app is really confusing.” Her mother is frustrated with Katie for not paying attention to the CGM, saying, “She can text her friends without any problem; I don’t know why she struggles with the CGM”.
As the diabetes healthcare provider, how can you support Katie in improving her glycemic control?

Answer A is incorrect: 12.89% chose this answer, “Turn on her CGM alarms but increase the high alarm so she doesn’t get as many
hyperglycemia related alerts.” Helping Katie turn on and increasing her high alarm will not help improve her glycemic management.
Answer B is correct: 76.5% chose this answer, “Show her step-by-step how to use the app and how to troubleshoot the alerts and alarms.” Guiding Katie through the CGM app and its functions helps her ask questions, resolve issues, and better monitor her glycemic management.
Answer C is incorrect: 9.46% chose this answer, “Have the school nurse monitor her CGM trends when Katie is at school, since her mom monitors the CGM trends when she is at home.” Asking the school nurse to monitor CGM data while Katie is at school is not helping to improve Katie’s self-management skills.
Answer D is incorrect: 1.15% chose this answer, “Email Katie’s mother once a week for updates to make sure she is monitoring CGM
trends.” Emailing Katie’s mother does not help improve Katie’s CGM self-monitoring skills or her confidence level with the CGM app.
We hope you appreciate this week’s rationale! Thank you so much for taking the time to answer our Question of the Week and participate in this fun learning activity!

Gain fresh insights, practical tools, and a deeper understanding of the latest in person-centered diabetes care. Our expert team brings the ADA Standards of Care to life—covering medications, behavior change, technology, and more!
If you’re preparing for the CDCES or BC-ADM exam, this conference, paired with a handful of free bonus courses, serves as the ideal study companion! Plus, this content counts toward the ADA Standards requirements for CDCES Renewal.
With interactive co-teaching, we keep sessions engaging, relevant, and fun.
Let’s learn and grow together!
Course credits through AMA PRA Category 1 Credits™, ACPE, ANCC, and CDR!
Program Objectives:
Upon completion of this activity, participants should be able to:
For last week’s practice question, we quizzed participants on the new ADA Standards and the development of type 2 diabetes. 42.48% of respondents chose the best answer. We want to clarify and share this important information, so you can pass it on to people living with diabetes and your colleagues, plus prepare for exam success!
Before we start though, if you don’t want any spoilers and haven’t tried the question yet, you can answer it below: Answer Question

According to the new 2026 ADA Standards, “type 2 diabetes is associated with insulin secretory defects related to” which of the following?

Answer A is incorrect: 14.85% chose this answer, “BMI and activity level.” This answer is incorrect but tempting. BMI level is used as a a screening tool for prediabetes and diabetes risk, but is not included as a factor contributing to secretory defects. According to the ADA, there are four factors related to insulin secretory defects in type 2 diabetes. They include; genetics, epigenetics, metabolic stress and inflammation.
Answer B is incorrect: 16.92% chose this answer, “Lifestyle and inflammation.” This juicy answer is incorrect. Lifestyle is not a direct factor related to insulin secretory defects, but inflammation is a contributor. According to the ADA, there are four factors related to insulin secretory defects in type 2 diabetes. They include; genetics, epigenetics, metabolic stress and inflammation.
Answer C is incorrect: 25.75% chose this answer, “Genetics and visceral adipose distribution.” This answer is incorrect. Visceral adiposity is associated with an increased risk for diabetes, but does not contribute to insulin secretory defects. According to the ADA, there are four factors related to insulin secretory defects in type 2 diabetes. They include; genetics, epigenetics, metabolic stress and inflammation.
Answer D is correct: 42.48% chose this answer, “Epigenetics and metabolic stress.” This answer is correct, GREAT JOB! According to the ADA, there are four factors related to insulin secretory defects in type 2 diabetes. They include; genetics, epigenetics, metabolic stress and inflammation.
We hope you appreciate this week’s rationale! Thank you so much for taking the time to answer our Question of the Week and participate in this fun learning activity!

Our GLP-1 & GIP Meds PocketCard now includes two distinct versions—one for diabetes and one for weight management—so you can compare therapies at a glance.
Each version clearly outlines:
This side-by-side approach makes it easier to individualize treatment decisions based on a person’s health profile, age, and comorbidities.
Big news in the GLP-1 world! Semaglutide is now available as an oral formulation for weight loss, and we’ve added it to the PocketCard.
Just like Rybelsus, oral semaglutide for weight loss:
It’s the end of an era. Exenatide XR (Bydureon®, Bcise®) has been discontinued.
The only remaining option is generic exenatide, administered twice daily—still available and noted on the updated PocketCard.
We say goodbye to rosiglitazone and welcome a renewed appreciation for pioglitazone (Actos®).
Pioglitazone:
Research led by Dr. Ralph DeFronzo demonstrates that pioglitazone can shift fat from visceral to subcutaneous depots, improving metabolic health and liver outcomes.
Clinical pearls included on the card:
Importantly, pioglitazone is also indicated for people with prediabetes or diabetes who have experienced a stroke, as it significantly reduces the risk of recurrent stroke.
DPP-4 inhibitors continue to decline in use due to lower efficacy and higher cost, and both alogliptin and saxagliptin carry an increased risk of hospitalization for heart-failure .
That said, generic saxagliptin is once again available, so we’ve added it back to the PocketCard in the DPP-4 category—clearly labeled to support informed prescribing.


CS is a 42-year-old with type 1 diabetes for just over 18 years. In the past year, their A1C changed from 7.4% to 9.1%, and weight increased by 20 pounds. Review of CGM data suggests missed insulin boluses more than 7 times per week, and discussion with CS reveals missed clinic visits due to feeling “burned out”. They score in the moderate range on the Diabetes Distress Scale.
Based on the ADA 2026 Standards of Care, which of the following is the most appropriate next step?



If you’ve considered not renewing your professional practice group membership this year, you’re not alone. Membership in professional organizations has declined as many turn to social media and AI-driven platforms for information and connection. Still, I encourage you not to abandon professional membership in favor of options that may seem cheaper or more convenient.
In a noisy, chaotic landscape of information overload, professional practice groups remain a refuge from the storm. They offer a trusted alternative to clickbait, providing vetted expertise, meaningful connection, and true professional community.
No amount of viral TikTok videos or LinkedIn commentary can replace the depth of connection and sense of purpose that come from active engagement in a professional practice organization. And, here’s why.
Professional practice groups, also known as professional practice organizations, are designed to advance a specific field by providing members with networking opportunities, professional development, and practice resources. In healthcare, these organizations may be tailored to the needs of a single discipline, such as the American Nurses Association, or span interdisciplinary areas of practice, like the Association of Diabetes Care and Education Specialists or the American Diabetes Association.
Some organizations focus primarily on education and credentialing, while others emphasize leadership development and community building. Still others center their work on advocacy related to patient care, access, and insurance coverage.
At its core, most professional practice groups are founded and driven by their members, with membership dues supporting the administrative needs required to operate. As groups grow, they often engage professional management or organizational leadership teams to oversee day-to-day operations such as membership services, programming, finances, legal compliance, and other administrative functions.
Strategic direction and oversight typically remain the responsibility of an elected or appointed governing body. In some cases, professional organizations may choose to hire members, transitioning them from volunteer roles into paid staff positions.
As operating costs rise, often without corresponding increases in salaries or reimbursement, many professional practice groups partner with industry or government organizations for additional financial support. These partnerships can help keep membership dues, educational programming, and events accessible and affordable for members.
It would be easy to blame declining professional membership on COVID, but the reality is this trend started long before the pandemic. Across healthcare, fewer clinicians are joining or renewing professional organizations. Cost is often the biggest factor. When budgets are tight, many people feel forced to choose one membership instead of several. Others question whether the return on investment is still there, especially when education, networking, and professional content are now easy to find online for free.
In my own field of dietetics, I also hear concerns about transparency and alignment with the future of the profession. The move to a master’s degree requirement without a meaningful increase in entry-level pay has created real frustration, particularly for early-career professionals and those from underrepresented backgrounds. Many feel their needs were not fully considered or advocated for during that transition.
These frustrations are valid. But they are also exactly why walking away may not be the answer. Professional practice groups are shaped by the people who show up. If something isn’t working, the most effective way to change it is to get involved.
Despite the challenges, the benefits of professional membership far outweigh the drawbacks, and the opportunity to influence the future of your profession is worth staying engaged.
Social media platforms like LinkedIn, Substack, and X (formerly Twitter) are great for ideas and inspiration, but they rarely offer sustained, reciprocal mentorship. Most interactions are brief, one-sided, or tied to someone selling something.
Professional practice groups offer something different. They foster trusted relationships with people who have walked the same path and understand the realities of the work. Advice is shared openly, support develops over time, and there is no sales funnel attached. It is not a transaction. It is a co-op.
Professional practice groups offer a space to ask questions without worrying about who is watching or how you are being perceived. There is room to be unsure, curious, or quietly ambitious, especially early in your career or during periods of transition.
Unlike social media, which often rewards confidence and visibility, professional groups tend to reward competence, growth, and thoughtful engagement. The focus is less on performance and more on learning and supporting one another as professionals.
Most online content is designed for reach, not rigor. Professional practice groups focus on depth, offering evidence-based, peer-reviewed insights shared by professionals, for professionals. It is not about trends. It is about trust. As these professional practice groups evolve, many are also opening the door to honest conversations about topics once considered off-limits, such as workplace culture, compensation, and career options.
I’ve made meaningful connections on social media and learn something new every day from tools like ChatGPT. Those platforms have their place.
But when I want to understand where a profession is really headed, I look to professional practice groups. Who is presenting the research? What study resources are being recommended? Who is mentoring, volunteering, and helping shape the future of the field? These groups create space to contribute, learn, and grow alongside peers who care deeply about the work.
I’ve always respected my work colleagues, but I truly value my professional practice peers. I hope you will, too.
References:
Sarah is the owner of Sarah Hormachea: Diabetes Care and Education, LLC. She is a long-time member of the Academy of Nutrition and Dietetics, the Association of Diabetes Care and Education Specialists (ADCES), and the American Diabetes Association (ADA). She currently serves as Webinar Chair for the Academy’s Diabetes Practice Group and is an incoming member of the ADCES Board of Directors. She is also enrolled in a women’s leadership development program through the ADA.
For last week’s practice question, we quizzed participants on which feature most strongly supports a diagnosis of hyperosmolar hyperglycemic state (HHS) rather than diabetes ketoacidosis (DKA). 59.77% of respondents chose the best answer. We want to clarify and share this important information, so you can pass it on to people living with diabetes and your colleagues, plus prepare for exam success!
Before we start though, if you don’t want any spoilers and haven’t tried the question yet, you can answer it below: Answer Question

A 32-year-old with newly discovered diabetes is brought to the emergency department with polyuria and lethargy. They have been sleeping more than usual.
Initial labs show:
Based on the following labs, which feature most strongly supports a diagnosis of hyperosmolar hyperglycemic state (HHS) rather than diabetes ketoacidosis (DKA)?

Answer A is incorrect: 14.21% chose this answer, “Markedly elevated plasma glucose.” This answer is tempting, because glucose levels do become markedly elevated with HHS. However, very high glucose levels can also occur with DKA. So this answer doesn’t differentiate between these two hyperglycemic crises.
Answer B is incorrect: 21.38% chose this answer, “Absence of significant metabolic acidosis.” This juicy answer is tempting, since with HHS there is the absence of metabolic acidosis. However, based on the question details, there is no information on pH or ketone status, so we can’t make that assumption.
Answer C is incorrect: 4.64% chose this answer, “Out of range potassium level.” The potassium level of 3.7 is within normal range and doesn’t help us differentiate between HHS and DKA.
Answer D is correct: 59.77% chose this answer, “Elevated effective serum osmolality.” YES, this is the BEST Answer. Great Job! One of the main features of HHS, is increased serum osmolality (greater than 300), due to a combination of elevated glucose and dehydration.
We hope you appreciate this week’s rationale! Thank you so much for taking the time to answer our Question of the Week and participate in this fun learning activity!

Sale Ends on February 16th, 2026!
For last week’s practice question, we quizzed participants on which of the following responses is the least appropriate (i.e., the WRONG thing to say) to Maria. % of respondents chose the best answer. We want to clarify and share this important information, so you can pass it on to people living with diabetes and your colleagues, plus prepare for exam success!
Before we start though, if you don’t want any spoilers and haven’t tried the question yet, you can answer it below: Answer Question

Maria, a 52‑year‑old woman with type 2 diabetes for 8 years, attends a follow‑up visit. Her A1C has risen from 7.8% to 9.2% over the past year. She reports feeling “overwhelmed” and says she didn’t want to start the medication her clinician recommended at the last visit. She explains, “I’m scared of side effects, and I feel like needing medication means I failed.”
Which of the following responses is the least appropriate (i.e., the WRONG thing to say) to Maria?
Answer A is incorrect: % chose this answer,“ It sounds like you’re feeling overwhelmed. Can you tell me more about what worries you most about starting this medication?” Appropriate — Person centered, exploratory. This response uses reflective listening and invites the patient to share her concerns. It aligns with ADA Standards of Care recommendations for collaborative communication and supports assessment of diabetes distress.
Answer B is incorrect: % chose this answer, “Many people feel this way. Let’s look at your options together so you can make a choice that works for you.” Appropriate — Normalizes feelings and supports shared decision making. This option reduces stigma by acknowledging that many people experience similar emotions. It reinforces autonomy and partnership, which are core components of effective diabetes self management support.
Answer C is correct: % chose this answer, “I understand that this is challenging and overwhelming. However, if you don’t start this medication, you are choosing to risk complications like kidney disease or blindness.” Incorrect — Stigmatizing, blaming, and fear based. This statement uses threat based language (“you are choosing to risk complications…”) and implies personal failure. It increases shame, undermines trust, and can worsen diabetes distress. It does not incorporate person first language or collaborative care or help identify barriers and personalized solutions. Oh, and it probably won’t be very successful!
Answer D is incorrect: % chose this answer, “It’s completely understandable to have concerns. Would it help if we reviewed what the medication does, talk about the pro’s and the con’s, and about what alternatives exist?” Appropriate — Validates concerns and offers. Information without pressure. This response acknowledges the patient’s emotions and provides an opening for education and shared exploration of options. It supports autonomy and reduces the sense of failure associated with medication use.
We hope you appreciate this week’s rationale! Thank you so much for taking the time to answer our Question of the Week and participate in this fun learning activity!

In this course, William H. Polonsky, PhD, CDCES, and Susan Guzman, PhD, examine the powerful role of psychosocial factors in diabetes self-management. Through innovative strategies, participants will learn how to recognize and address common barriers to effective self-care and cardiometabolic medication initiation and maintenance, while fostering respectful, stigma-free clinical encounters.
Through a collaborative and person-centered approach, the course emphasizes communication strategies that enhance motivation, build confidence, and reinforce the value of self-management. Participants will develop skills in diabetes-focused action planning, addressing medication hesitancy, and providing ongoing support and resources to sustain behavior change over time. The goal is to help clinicians make diabetes care more doable, meaningful, and effective for people living with diabetes.
Diabetes Education Services offers education and training to diabetes educators in the areas of both Type 1 and Type 2 Diabetes for the novice to the established professional. Whether you are training to be a Certified Diabetes Care and Education Specialist (CDCES), practicing at an advanced level and interested in board certification, or a health care professional and/or Certified Diabetes Care and Education Specialist (CDCES) who needs continuing education hours to renew your license or CDCES, we have diabetes education information, resources and training; learning and teaching tools; and diabetes online courses available for continuing education (CE). Read our disclaimer for full disclosure.